These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 24152086

  • 1. Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.
    Allen A, Bal J, Cheesbrough A, Hamilton M, Kempsford R.
    Br J Clin Pharmacol; 2014 May; 77(5):808-20. PubMed ID: 24152086
    [Abstract] [Full Text] [Related]

  • 2. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT, Deans A, Mehta R, Sousa AR.
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects.
    Chen X, Zheng X, Jiang J, Hu P, Wu K, Zhuang L, Liu L, Du X, Kempsford R, Allen A.
    Pharmacotherapy; 2015 Jun; 35(6):586-99. PubMed ID: 26059225
    [Abstract] [Full Text] [Related]

  • 4. The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.
    Kempsford R, Allen A, Bareille P, Hamilton M, Cheesbrough A.
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):2-11. PubMed ID: 27127998
    [Abstract] [Full Text] [Related]

  • 5. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
    Allen A, Bareille PJ, Rousell VM.
    Clin Pharmacokinet; 2013 Jan; 52(1):37-42. PubMed ID: 23184737
    [Abstract] [Full Text] [Related]

  • 6. Population Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease.
    Siederer S, Allen A, Yang S.
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):743-758. PubMed ID: 26474864
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
    Vutikullird AB, Gillespie M, Song S, Steinfeld J.
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
    [Abstract] [Full Text] [Related]

  • 8. The safety, pharmacokinetics and pharmacodynamics of a combination of fluticasone furoate and vilanterol in healthy Japanese subjects.
    Nakahara N, Wakamatsu A, Kempsford R, Allen A, Yamada M, Nohda S, Hirama T.
    Int J Clin Pharmacol Ther; 2013 Aug; 51(8):660-71. PubMed ID: 23735179
    [Abstract] [Full Text] [Related]

  • 9. The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects.
    Kempsford R, Allen A, Bal J, Rubin D, Tombs L.
    Br J Clin Pharmacol; 2013 Jun; 75(6):1478-87. PubMed ID: 23116485
    [Abstract] [Full Text] [Related]

  • 10. Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination.
    Ambery C, Riddell K, Daley-Yates P.
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):399-407. PubMed ID: 27170445
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
    Mehta R, Moore A, Riddell K, Joshi S, Chan R.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
    [Abstract] [Full Text] [Related]

  • 12. A randomized, crossover study to investigate the pharmacokinetics and safety of inhaled fluticasone furoate and umeclidinium, administered separately and in combination via dry powder inhaler in healthy adult volunteers.
    Yang S, Lee L, Mallett S, Ayer J, Wolstenholme A, Pascoe S.
    Adv Ther; 2015 Feb; 32(2):157-71. PubMed ID: 25700806
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers.
    Brealey N, Gupta A, Renaux J, Mehta R, Allen A, Henderson A.
    Int J Clin Pharmacol Ther; 2015 Sep; 53(9):753-64. PubMed ID: 26227101
    [Abstract] [Full Text] [Related]

  • 14. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 15. Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study.
    Cella M, Täubel J, Delestre-Levai I, Tulard A, Vele A, Georges G.
    Clin Ther; 2021 Nov; 43(11):1934-1947.e4. PubMed ID: 34600734
    [Abstract] [Full Text] [Related]

  • 16. Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.
    Oliver A, VanBuren S, Allen A, Hamilton M, Tombs L, Inamdar A, Kempsford R.
    Clin Ther; 2014 Jun 01; 36(6):928-939.e1. PubMed ID: 24793536
    [Abstract] [Full Text] [Related]

  • 17. Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN).
    Yang S, Lee LA, Sule N, Fowler A, Peachey G.
    Clin Pharmacokinet; 2021 Jul 01; 60(7):887-896. PubMed ID: 33598874
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.
    Allen A, Murdoch RD, Bareille P, Burns O, Hughes S, Gupta A, Miller SR.
    Clin Pharmacol Drug Dev; 2016 May 01; 5(3):225-31. PubMed ID: 27163502
    [Abstract] [Full Text] [Related]

  • 19. A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects.
    Kempsford R, Allen A, Kelly K, Saggu P, Crim C.
    Br J Clin Pharmacol; 2014 Mar 01; 77(3):466-79. PubMed ID: 24093504
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study.
    Shimada S, Vaidya S, Khindri S, Tashiro N, Cheng Y, Hara H, Majumdar T, Woessner R, Furihata K, Kobayashi K.
    Int J Clin Pharmacol Ther; 2015 May 01; 53(5):398-407. PubMed ID: 25740265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.